A Boston-based company has passed an important hurdle in its effort to get FDA approval for its ovarian-cancer treatment.

Black Diamond Therapeutics shows promise with BDTX-1535 for NSCLC treatment. Click here to find out why I rate BDTX stock a ...

Champoins Oncology broke out of a multiyear downtrend following its Q2'25 earnings. Check out why I rate CSBR stock as a Buy.

Verastem Oncology said its treatment for recurrent low-grade serous ovarian cancer has been given priority review by the Food and Drug Administration. The new drug application for the treatment in ...

Race Oncology hopes its repurposed drug candidate bisantrene can protect the heart from the dangerous effect of chemotherapy.

Kura Oncology Inc (KURA) stock saw a decline, ending the day at $8.51 which represents a decrease of $-0.16 or -1.85% from the prior close of $8.67. The stock opened at $8.65 and touched a low of ...

Sharon Manson's 45-year career in oncology nursing includes roles from bedside nurse to assistant vice president of oncology ...

Here are the top 5 articles from 2024 reported on Oncology Nursing News. Opinion: The Media May Have Oversold AOH1996, City ...

Ikena Oncology ( (IKNA) ) has provided an announcement. Ikena Oncology and Inmagene Biopharmaceuticals have announced a ...

This year’s most-read oncology content of 2024 includes topics on clinical trials, drug access, vaping and lung cancer, and ...

Evorpacept is under clinical development by ALX Oncology and currently in Phase II for Relapsed Multiple Myeloma.